Has Neurocept publicly posted responses or corrective actions addressing BBB complaints?
Executive summary
Available BBB profiles show at least one complaint filed against Neurocept (or variant spellings) marked as "failure to respond," and independent consumer sites and reviews document multiple complaints and allegations of scammy marketing, but the provided sources do not show a public, formal Neurocept response or corrective-action statement posted to the BBB pages [1] [2] [3]. Trustpilot and other review sites record consumer reports and claims of deepfake ads and billing problems but do not include an official company remediation post [3] [4].
1. BBB records indicate complaints but show no company reply on the cited profiles
The Better Business Bureau entries for Neurocept (and a near-identical listing, “Neuerocept”) both flag a “Failure to respond to 1 complaint filed against business,” which is what the BBB publicly displays on those profile pages [1] [2]. Those BBB snippets identify complaint counts and note the files opened dates but do not include any company-authored response text or a corrective-action statement on the cited pages [1] [2]. Available sources do not mention a BBB-posted company reply addressing those complaints.
2. Consumer-review platforms document complaints but not formal company corrective actions
Trustpilot and other review outlets include multiple consumer posts alleging deceptive marketing, unwanted charges, or being advised to contact the BBB — and reviewers state they notified the BBB — yet these posts do not show that Neurocept published an official corrective-action plan in response on those platforms [3]. Independent blog and review sites go further, calling the product a “scam” and alleging deepfake endorsements, but they are user-focused investigations rather than records of company remediation [4] [3].
3. Specific consumer complaints reported in public postings
Examples in the collected sources include allegations of misleading ads, deepfake celebrity endorsements, charge disputes, and texts flagged as scam numbers after purchase — claims appearing both as user posts on Trustpilot and as an entry in BBB’s Scam Tracker [3] [5]. Those consumer reports document harm and frustration but do not show a public Neurocept corrective action or a company statement posted to the BBB records contained in the supplied search results [5] [3].
4. Regulatory and historical context that matters to readers
The Federal Trade Commission previously took action against other pill marketers that used deceptive mail or fake endorsements — demonstrating that this marketing pattern has triggered enforcement in comparable cases [6]. That FTC precedent helps explain why consumer complaints alleging fake doctor endorsements or deceptive ads attract attention; the available sources do not state whether Neurocept itself is subject to such regulatory action, only that similar schemes have led to FTC enforcement [6]. Available sources do not mention any FTC action against Neurocept specifically.
5. Two plausible interpretations and their implications
One interpretation is that Neurocept has not engaged with the BBB complaint entries cited here, since the BBB pages explicitly flag “failure to respond” [1] [2]. The alternative is that the company may have communicated off-platform (directly with customers, payment processors, or state agencies) or changed operations without updating the BBB profile; the sources do not document any off-BBB corrective actions by the company. Readers should weigh both possibilities because the absence of a BBB-posted reply is not definitive proof of no company activity beyond these public pages.
6. Limitations and what sources do not say
The dataset here is limited to the supplied pages: BBB profiles, a BBB Scam Tracker report, Trustpilot, and several review blogs [1] [5] [3] [4]. These sources do not include Neurocept’s own corporate site, press releases, direct communications to customers, filings with regulators, or later updates to BBB profiles beyond the snippets provided. Therefore, claims about company conduct beyond what these pages show would be unsupported by the current reporting. Available sources do not mention a Neurocept-published corrective action posted to the BBB.
7. What consumers can do and what to watch for next
Consumers wanting verification should check the live BBB profile and Scam Tracker entries, request transaction documentation and chargebacks from payment providers, and look for any press statements or regulatory notices (not found in the supplied sources) that would document formal corrective actions. Given the pattern of complaints and the FTC’s history with similar marketers, consumers should preserve receipts and communications while monitoring official agency actions and any updated BBB responses [1] [6].